Licences Cancelled for Distributor and Manufacturer Linked to Rajasthan Oxytocin Deaths
The Rajasthan drug control department cancelled the licence of a Kota-based pharmaceutical distributor, Rajasthan Medical Hall, for supplying spurious oxytocin injections linked to the deaths of five women after Caesarean sections in May. Investigations revealed the injections contained no oxytocin and discrepancies in procurement records. The manufacturing licences of Jackson Laboratories' units in Punjab and Himachal Pradesh were also revoked following inspections citing regulatory violations. The World Health Organization has requested details from India as part of routine pharmacovigilance, while the Centre seeks a detailed report from Rajasthan authorities.
First-hand measurement across 11 sources
We measured how 11 outlets covered this story. Coverage leans balanced overall (Left 17%, Centre 78%, Right 5%). Overall sentiment is negative (33/100). Lens Score 59/100 — moderate public interest.
Outlets analysed (first-hand measurement by TBN's Bias Engine):
- indianexpress— balanced framing, negative sentiment
- economictimes— balanced framing, negative sentiment
- thehindu— balanced framing, neutral sentiment
- economictimes— balanced framing, neutral sentiment
- businessstandard— balanced framing, neutral sentiment
- ndtv— balanced framing, neutral sentiment
- indiatoday— balanced framing, neutral sentiment
- indianexpress— balanced framing, negative sentiment
AI Analysis
The article group presents perspectives primarily from government regulatory bodies and health officials, focusing on factual reporting of licence cancellations and investigations. It includes statements from the World Health Organization and Indian health authorities, reflecting official responses without partisan framing. The coverage emphasizes regulatory actions and procedural follow-ups, with no evident political positioning or critique of specific parties.
The overall tone across the articles is serious and cautious, reflecting concern over maternal deaths and drug safety issues. While the reports highlight regulatory failures and tragic outcomes, they maintain a neutral, fact-based approach without sensationalism. The inclusion of WHO's routine inquiry and government investigations adds a measured, procedural sentiment rather than alarm or blame.